PRMT7 anticorps (full length)
Aperçu rapide pour PRMT7 anticorps (full length) (ABIN7878879)
Antigène
Voir toutes PRMT7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- PRMT7 Antibody
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant full-length human protein was used as the immunogen for the PRMT7 antibody.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal dilution of the PRMT7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the PRMT7 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
-
Autre désignation
- PRMT7
-
Sujet
- Arginine methylation is an irreversible protein modification catalyzed by Arginine methyltransferases, such as PRMT7, which uses S-adenosylmethionine (AdoMet) as the methyl donor. Arginine methylation is implicated in signal transduction, RNA transport and RNA splicing. PRMT7 has two methyltransferase domains, each containing a putative AdoMet-binding motif. The N-terminal methyltransferase domain closely resembles the catalytic core of PRMT5, and the C-terminal domain is most similar to that of PRMT1. Three PRMT7 splice variants have been identified by database analysis. PRMT7 is localized to the nucleus and cytoplasm and moderate expression is observed in adult brain and lung tissues.
-
UniProt
- Q9NVM4
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-